pharmaphorum

FEBRUARY 11, 2021

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. Linking pharma with patients.

Clinical Trials 89

Clinical Trials Clinical Trials Trials Clinical Research 89

pharmaphorum

FEBRUARY 1, 2022

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?

Clinical Trials 86

Clinical Trials Clinical Trials Trials Engineer 86

pharmaphorum

MARCH 2, 2022

Ben Hargreaves discovers why medical research in the area has shifted from being highly controversial to being backed by major pharma companies and venture capital. The image of psychedelic drugs within medical research is changing. A psychedelic renaissance.

Life Science 94

Life Science Clinical Trials Clinical Trials Trials 94

pharmaphorum

JULY 7, 2022

Eradicating cancer is an ambitious goal for oncologists and life science companies around the world. But, with a growing number of cancer treatments entering the market each year and dedicated research efforts driving innovation in the sector, there are positive signs that the industry is on the right track.

Vaccination 52

Vaccination Vaccine Life Science Trials 52

Drug Discovery World

OCTOBER 16, 2023

Here, DDW’s Megan Thomas highlights the research taking place and where this is happening. This environment of research excellence, in turn, fosters R&D, innovation, spin-offs, start-ups, networking, collaboration and entrepreneurship, which sets a sturdy foundation that attracts funding, and creates an appealing work culture.

Drugs 75

Drugs Life Science Gene Therapy Genome 75

pharmaphorum

DECEMBER 23, 2020

The capital injection will support wide-ranging plans for the new year that include several life sciences programmes in surgery, pathology and immunology, which would add to the digital ophthalmology joint venture it signed with Japan’s Santen in February. Meanwhile, the last 12 months have seen a refocusing at Onduo.

Life Science 58

Life Science Pharma Companies Clinical Research Production 58

pharmaphorum

DECEMBER 16, 2020

Soon the ABPI and the entire industry were facing the ripple effects of COVID-19, including a significant slowdown in non-COVID clinical research, which Torbett says was challenging for the industry to deal with. “We’ve We had companies collaborating to develop laboratories. A collaborative future.

Vaccination 120

Vaccination Vaccine Life Science In-Vitro 120

pharmaphorum

MAY 27, 2022

The adoption of digital healthcare tools in clinical research accelerated dramatically during the COVID-19 pandemic and it is expected that such tools will continue to contribute to clinical research in the future. What comes next?

Clinical Trials 79

Clinical Trials Clinical Trials Trials Packaging 79

pharmaphorum

AUGUST 31, 2021

For the healthcare ecosystem to drive research and care, clarity is needed about the opportunities and challenges of ECAs and their value in bringing therapies to patients faster, say COTA Viraj Narayanan and Karla Feghali from ConvergeHEALTH by Deloitte. Myth 3: RWD is too imperfect to be used to as a comparator arm to a clinical trial.

Clinical Trials 63

Clinical Trials Clinical Trials Life Science Trials 63

XTalks

MAY 6, 2022

In this interview, Xtalks spoke with experts from eClinical Solutions , Katrina Rice, Chief Delivery Officer, Data Services; and Diane Lacroix, Vice President, Clinical Data Management, about clinical data management for modern day digital clinical trials. Clinical Data Pipeline for Data Review and Analyses.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Life Science 98

pharmaphorum

DECEMBER 15, 2022

Co-chaired by Lord James O’Shaughnessy and Professor Mike Bewick, former deputy national medical director of NHS England (present online), the NHS Innovation and Life Sciences Commission Report launch took place at One Great George Street, Westminster, on 12th December 2022. The UK as a powerhouse of research.

Life Science 81

Life Science Medicine Clinical Trials Clinical Trials 81

The Pharma Data

SEPTEMBER 11, 2020

In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US. “The Saama Technologies, Inc. ,

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

pharmaphorum

JULY 8, 2022

The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinical trial space. Hybrid or decentralised clinical trials (DCTs) have gained traction as technology, infrastructure and knowledge have evolved to support their use. Novel digital endpoints. About the interviewees.

Clinical Trials 74

Clinical Trials Clinical Trials Trials Regulation 74

pharmaphorum

APRIL 7, 2021

While the Darzalex revenues are due to fall this year because of Janssen’s interpretation of the agreement between the two companies, there are also other revenue streams. With other drugs in the pipeline too, van de Winkel said the company aims to continue to break new ground with next-generation antibody-based therapies. Role models.

Antibody 65

Antibody Life Science Development Regulation 65

XTalks

SEPTEMBER 5, 2023

Xtalks spoke with Maria Reyes Boceta-Muñoz, Clinical Operations Head of Development R&D at GlaxoSmithKline in Spain, Portugal & Israel, to understand the current vaccine development climate and where the sector is headed. What are the major challenges you’re facing right now in vaccine development?

Vaccination 96

Vaccination Vaccine Development Clinical Trials 96

Cloudbyz

MAY 19, 2021

Introduction Cell and gene therapy is an upcoming wave of therapeutic innovation in the healthcare and life sciences industry and is being pragmatically accepted worldwide. billion in 2030 (Source: the business research compan y). billion in 2020 and is further expected to reach $34.31

Gene Therapy 52

Gene Therapy Gene Manufacturing Production 52

XTalks

AUGUST 18, 2020

The test has been developed by researchers at the Yale School of Public Health and is being touted as a game changer for fast and easy COVID testing. Yale commented that SalivaDirect does not rely on proprietary technology, and so the study researchers do not intend to commercialize it. Non-Proprietary Technology. Yale-NBA Partnership.

FDA Approval 90

FDA Approval Reagent RNA Genome 90

The Pharma Data

DECEMBER 17, 2020

He previously spent more than a decade at Medtronic in the company ’ s Minimally Invasive Therapies Group where he served as the global vice president and General Manager of General Surgery, and in various roles working on research, development, and strategy. AB2 Bio – Swiss pharma company AB2 Bio Ltd.

Development 52

Development Gene Therapy Engineer Life Science 52

Drug Discovery World

JANUARY 24, 2023

But Jeffrey Petrella, Professor of Radiology and Director of the Alzheimer Imaging Research Laboratory at Duke University School of Medicine, says: “Despite these limitations, this is the first step towards tailored clinical trials. However, it also made great strides in proving the success of these sorts of trials.

Clinical Trials 97

Clinical Trials Clinical Trials Drugs Trials 97

XTalks

MAY 11, 2023

Wendy: RARE-X is now the data and research arm of Global Genes, the flagship patient organization representing rare, ultra-rare, and “n-of-one” patients. Meaning, the patient experience, viewed in a scientific way, builds trust and enables us to research outcomes and endpoints that matter. We know this works.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Development 97

XTalks

OCTOBER 1, 2020

WeiQi Lin, MD, PhD, executive vice president of research & development and principal scientist, DURECT Corporation. Lin has made several transitions throughout her career, from being a clinician at an academic center, to academic research, to heading business development in industry. Motivations for Transition.

Scientist 52

Scientist In-Vitro Research Life Science 52

Drug Discovery World

OCTOBER 7, 2022

Earlier this year, Cancer Research UK (CRUK) launched its innovation engine, Cancer Research Horizons, to streamline drug discovery through the combination of its commercial and therapeutics teams. RA: Could you tell us about Cancer Research Horizons? . This is about changing how we operate. Hamish Ryder.

HR 52

HR Research Drugs Development 52

pharmaphorum

OCTOBER 10, 2022

We did extensive market research in many locations to gather insights into the current situation, including what patients like to see and what kind of campaign would actually help to activate them. The pharma industry has an important role to play in the future of cancer treatment and research.

Development 89

Development Research Marketing Life Science 89

pharmaphorum

NOVEMBER 15, 2021

.” After his 11-month stint heading the agency, Califf returned to his role as a cardiologist whilst also serving as a health policy and strategy advisor to Google’s unit life sciences unit Verily and running Duke University’s Clinical Research Institute, which he founded in 1996.

Regulation 85

Regulation Life Science Pharma Companies Branding 85